captopril Search Results


enamine z19802699 435 449 ndm  (Enamine Ltd)
96
Enamine Ltd enamine z19802699 435 449 ndm
Enamine Z19802699 435 449 Ndm, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/pm30107123__ci8b00133_si_001-12-14-14
Average 96 stars, based on 1 article reviews
enamine z19802699 435 449 ndm - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
captopril  (MedChemExpress)
94
MedChemExpress captopril
Captopril, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/pm38447360-44-0-7
Average 94 stars, based on 1 article reviews
captopril - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
captopril suppression test  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc captopril suppression test
Captopril Suppression Test, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/pm41454316-59-27-30
Average 93 stars, based on 1 article reviews
captopril suppression test - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
captopril  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology captopril
Figure 4. Effect of <t>captopril</t> on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.
Captopril, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/10__1080_slash_2162402x__2020__1836766-154-20-21
Average 93 stars, based on 1 article reviews
captopril - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
captopril  (Thermo Fisher)
94
Thermo Fisher captopril
Figure 4. Effect of <t>captopril</t> on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.
Captopril, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/pmc10655806-241-34-35
Average 94 stars, based on 1 article reviews
captopril - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
captopril  (Selleck Chemicals)
92
Selleck Chemicals captopril
Figure 4. Effect of <t>captopril</t> on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.
Captopril, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/pmc06527541-48-16-17
Average 92 stars, based on 1 article reviews
captopril - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
captopril cap  (Aladdin Scientific Corporation)
93
Aladdin Scientific Corporation captopril cap
Figure 4. Effect of <t>captopril</t> on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.
Captopril Cap, supplied by Aladdin Scientific Corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/10__1016_slash_j__jff__2024__106188-42-1-6
Average 93 stars, based on 1 article reviews
captopril cap - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
e 2s  (European Directorate for the Quality of Medicines and HealthCare)
90
European Directorate for the Quality of Medicines and HealthCare e 2s
Figure 4. Effect of <t>captopril</t> on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.
E 2s, supplied by European Directorate for the Quality of Medicines and HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril+impurity+E+CRS/10__24193_slash_subbchem__2019__2__19-75-26-30
Average 90 stars, based on 1 article reviews
e 2s - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
captopril  (Biosynth Carbosynth)
91
Biosynth Carbosynth captopril
Figure 4. Effect of <t>captopril</t> on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.
Captopril, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril/10__1523_slash_jneurosci__20___02___00639__2000-130-42-10
Average 91 stars, based on 1 article reviews
captopril - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
b 2s  (European Directorate for the Quality of Medicines and HealthCare)
90
European Directorate for the Quality of Medicines and HealthCare b 2s
Figure 4. Effect of <t>captopril</t> on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.
B 2s, supplied by European Directorate for the Quality of Medicines and HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/Captopril+impurity+B+CRS/10__24193_slash_subbchem__2019__2__19-75-13-16
Average 90 stars, based on 1 article reviews
b 2s - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
captopril  (FUJIFILM)
90
FUJIFILM captopril
Effects of nitrite and <t>captopril</t> supplementation on body, liver, and heart weights in the rat nonalcoholic steatohepatitis model. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, # p < 0.05 vs. SHRSP5/Dmcr + HFC diet group. SP diet, stroke-prone diet; HFC diet, high-fat/high-cholesterol diet; WKY, Wistar Kyoto rat.
Captopril, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/captopril/captopril/pmc08951310-100-4-10
Average 90 stars, based on 1 article reviews
captopril - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Figure 4. Effect of captopril on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.

Journal: OncoImmunology

Article Title: Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers

doi: 10.1080/2162402x.2020.1836766

Figure Lengend Snippet: Figure 4. Effect of captopril on macrophages. (a to c) Human monocytes (n = 3) were differentiated for 6 d into M1 or M2 macrophages. (a and b) Expression level (mean MFI of 3 different donors) of different markers after cell staining with specific antibodies to analyze M1 and M2 differentiation by flow cytometry. (a) MFI z-score of markers expression at basal level. (b) Fold expression of the different markers analyzed by flow cytometry to compare human monocytes differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) or candesartan (10 µM). (c) Human monocytes were differentiated for 6 d into M1 or M2 macrophages with or without captopril (100 µM) and substance P concentration in cell supernatants was evaluated by ELISA. Data represent the mean of 3 different donors ± s.d. *, p < .05; **, p < .01. (d and e) MC38 tumor bearing mice were daily treated or not per os with 25mg/kg captopril with or without i.p. injections of 10mg/kg anti-PD-1 mAb three times a week. (d) Macrophage occurrence in tumors and CD206 expression in TAMs (n = 4 or 5 animals per group) were analyzed by flow cytometry. (e) Tumor size was monitored (mean ± s.e.m) and mice survival was calculated (n = 7 to 9 animals per group). *, p < .05; **, p < .01; ***, p < .005.

Article Snippet: Animals were treated from day 7 after tumor-cell injection (tumor size, 30 mm2), every day per os with 25 mg/kg captopril (Santa Cruz Biotechnology) in hypromellose and every 2–3 d i.p. with 10 mg/kg inVivo mAb anti-mouse PD-1 (BioXcell BE0146).

Techniques: Expressing, Staining, Flow Cytometry, Concentration Assay, Enzyme-linked Immunosorbent Assay

Effects of nitrite and captopril supplementation on body, liver, and heart weights in the rat nonalcoholic steatohepatitis model. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, # p < 0.05 vs. SHRSP5/Dmcr + HFC diet group. SP diet, stroke-prone diet; HFC diet, high-fat/high-cholesterol diet; WKY, Wistar Kyoto rat.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Effects of nitrite and captopril supplementation on body, liver, and heart weights in the rat nonalcoholic steatohepatitis model. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, # p < 0.05 vs. SHRSP5/Dmcr + HFC diet group. SP diet, stroke-prone diet; HFC diet, high-fat/high-cholesterol diet; WKY, Wistar Kyoto rat.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques:

Effects of nitrite and captopril on blood pressure in the rat nonalcoholic steatohepatitis model. Values represent mean ± SE ( n = 6), * p < 0.05, vs. the WKY + SP diet group, † p < 0.05, vs. the SHRSP5/Dmcr + SP diet group. SBP, systolic blood pressure; MBP, mean blood pressure; DBP, diastolic blood pressure.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Effects of nitrite and captopril on blood pressure in the rat nonalcoholic steatohepatitis model. Values represent mean ± SE ( n = 6), * p < 0.05, vs. the WKY + SP diet group, † p < 0.05, vs. the SHRSP5/Dmcr + SP diet group. SBP, systolic blood pressure; MBP, mean blood pressure; DBP, diastolic blood pressure.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques:

Macroscopic appearance and histological analysis (HE staining) of liver in WKY and SHRSP5/Dmcr rats fed SP diets and nonalcoholic steatohepatitis model rats treated with or without nitrite and captopril. Values represent mean ± SE ( n = 6), * p < 0.05, vs. the WKY + SP diet group, † p < 0.05, vs. the SHRSP5/Dmcr + SP diet group.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Macroscopic appearance and histological analysis (HE staining) of liver in WKY and SHRSP5/Dmcr rats fed SP diets and nonalcoholic steatohepatitis model rats treated with or without nitrite and captopril. Values represent mean ± SE ( n = 6), * p < 0.05, vs. the WKY + SP diet group, † p < 0.05, vs. the SHRSP5/Dmcr + SP diet group.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques: Staining

Immunohistochemical analysis of p47phox-positive area in the hepatic tissues of the rat nonalcoholic steatohepatitis model treated with nitrite and captopril. Results are expressed as mean ± SE ( n = 6), Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Immunohistochemical analysis of p47phox-positive area in the hepatic tissues of the rat nonalcoholic steatohepatitis model treated with nitrite and captopril. Results are expressed as mean ± SE ( n = 6), Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques: Immunohistochemical staining

Immunohistochemical analysis of CD68-positive area in the hepatic tissues of the rat nonalcoholic steatohepatitis model and the effects of nitrite and captopril on the inflammatory response in the liver. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Immunohistochemical analysis of CD68-positive area in the hepatic tissues of the rat nonalcoholic steatohepatitis model and the effects of nitrite and captopril on the inflammatory response in the liver. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques: Immunohistochemical staining

Histological analysis of liver fibrosis (Sirius Red stain) in the rat nonalcoholic steatohepatitis model treated with nitrite and captopril. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Histological analysis of liver fibrosis (Sirius Red stain) in the rat nonalcoholic steatohepatitis model treated with nitrite and captopril. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques: Staining

Gross photograph of midventricular short-axis section and quantitative analysis of left ventricular muscle area and chamber size following treatment with nitrite and captopril. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Gross photograph of midventricular short-axis section and quantitative analysis of left ventricular muscle area and chamber size following treatment with nitrite and captopril. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques:

Effects of nitrite and captopril supplementation on the plasma levels of NOx in the rat nonalcoholic steatohepatitis model. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group. NOx, nitrite, and nitrate.

Journal: International Journal of Molecular Sciences

Article Title: Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study

doi: 10.3390/ijms23062931

Figure Lengend Snippet: Effects of nitrite and captopril supplementation on the plasma levels of NOx in the rat nonalcoholic steatohepatitis model. Values represent mean ± SE ( n = 6), * p < 0.05 vs. WKY + SP diet group, † p < 0.05 vs. SHRSP5/Dmcr + SP diet group, ♯ p < 0.05 vs. SHRSP5/Dmcr + HFC diet group. NOx, nitrite, and nitrate.

Article Snippet: Sodium nitrite and the ACE inhibitor captopril were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).

Techniques: